Proprietary Technologies

Innovation is at the core of everything we do

Our proprietary technologies are purpose-built to overcome the most complex formulation and drug delivery challenges across topical, transdermal, mucosal, ophthalmic, and respiratory applications. From automated high-throughput testing systems like MedFlux-HT® for skin permeation studies to specialized models like ChubTur® for hard tissue and nail penetration, our technologies drive faster, more predictive development. These exclusive platforms not only accelerate product timelines but also generate robust, regulatory-ready data that improves confidence in formulation performance and clinical success. MedPharm’s proprietary solutions offer clients a distinct scientific and competitive advantage, helping them navigate regulatory hurdles and deliver best-in-class therapies to market.

MEDSPRAY®

MedSpray® is a patented formulation technology developed by MedPharm, referred to as a “patch-in-a-can.” It is designed for various applications by leaving a thin film on the skin or other tissue surfaces

MEDSTAT™

Unique design features along with automated collection provide significant reduction in variation associated with sampling and fluidics compared to manually operated VDC systems.

MEDFLUX®

MedFlux-HT® is an automated system of 32 flow-through diffusion cells for measuring the in vitro permeation and penetration of drugs into and through human skin (IVPT) . It can also be set up with other tissues determined by the medicine’s target site (e.g. mucosal, buccal, etc).

EYEVPT®

EyeVPT is a proprietary device that mimics the tear and clearance mechanism across regrown cornea.

HTPD®

Proprietary system that keeps skin alive for more than 30 days for topical and systemic treatment assessment.

MEDCAST®

MedCast revolutionizes nasal drug delivery research with advanced anatomical modeling. It goes beyond serving as a physical replica of the nasal cavity by providing actionable insights into formulation behavior, deposition patterns, and functional performance across diverse patient demographics and delivery objectives.